- Overview & Definition of Biosimilars
- The Difference Between Biosimilars & Generic Drugs
- How Biosimilars Work & Their Use
- Examples of Biosimilars
- Implications in Managing the Cost of Cancer Treatments
- Clinical Trials: How Biosimilar Research Contributes to Treatment Options
- The Benefits of Biosimilars
- Current Use in the Care of People Living with Cancer
- Manufacturing & Safety Issues
- Key Questions to Ask Your Health Care Team About Biosimilars
- Current & Future Perspectives
- Questions for Our Panel of Experts
Our Panel of Experts
Richard J. Gralla, MD, FACP
Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center
Jeffrey Crawford, MD
George Barth Geller Professor for Research in Cancer, Department of Medicine, Duke University School of Medicine, Co-Director, Solid Tumor Therapeutics Program, Duke Cancer Institute
Edward Li, PharmD, MPH, BCOP
Professor, University of New England College of Pharmacy
Carolyn Messner, DSW, OSW-C, FAPOS
Director of Education and Training, CancerCare
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).
To request continuing education paperwork, please email your name, profession, and address to firstname.lastname@example.org after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.
You can download the brochure for this workshop(79 KB)